CVS Health Corp. (NYSE: CVS) Q3 2020 earnings call dated Nov. 06, 2020
Corporate Participants:
Valerie C Haertel — Senior Vice President, Investor Relations
Larry J. Merlo — President and Chief Executive Officer
Karen S. Lynch — Executive Vice President, CVS Health and President, Aetna
Eva C. Boratto — Executive Vice President and Chief Financial Officer
Alan M. Lotvin — Executive Vice President, CVS Health and President CVS Caremark
Jonathan C. Roberts — Executive Vice President and Chief Operating Officer
Analysts:
Lisa Gill — J.P. Morgan — Analyst
Eric Percher — Nephron Research LLC — Analyst
Ricky Goldwasser — Morgan Stanley — Analyst
A.J. Rice — Credit Suisse — Analyst
Charles Rhyee — Cowen and Company — Analyst
George Hill — Deutsche Bank — Analyst
Lance Wilkes — Sanford C. Bernstein — Analyst
Michael Cherny — Bank of America Merrill Lynch — Analyst
Ann Hynes — Mizuho Securities — Analyst
Steven Valiquette — Barclays — Analyst
Justin Lake — Wolfe Research — Analyst
_____
To read the full earnings call transcript, click here.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Listen On
